Senior insider sale
President and CEO at VERA THERAPEUTICS, INC. — senior position signals high conviction
$6.48M
143.13K shares
FORDYCE MARSHALL plans to sell 143.13K shares of VERA THERAPEUTICS, INC. valued at approximately $6.48M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Exercise of Stock Options
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/18/2024 | Exercise of Stock Options Cash | 17.50K | — |
| Total | 17.50K | ||
Completed
Units to sell
17.50K
Market value
$821.5K
Units to sell
19.38K
Market value
$929.6K
Units to sell
30.63K
Market value
$1.52M
Units to sell
19.38K
Market value
$782.6K
Units to sell
15.63K
Market value
$597.6K
Units to sell
23.13K
Market value
$1.06M
Planned — Approximate Date
Units to sell
17.50K
Market value
$768.4K
Units
143.13K
Value
$6.48M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/11/2024 | 17.50K | $821.5K | — | Completed |
11/25/2024 | 19.38K | $929.6K | — | Completed |
11/13/2024 | 30.63K | $1.52M | — | Completed |
10/23/2024 | 19.38K | $782.6K | — | Completed |
10/9/2024 | 15.63K | $597.6K | — | Completed |
9/25/2024 | 23.13K | $1.06M | — | Completed |
| Planned — Approximate Date | ||||
12/18/2024 | 17.50K | $768.4K | NASDAQ | Planned |
| Total | 143.13K | $6.48M | ||